In the dynamic landscape of chemical synthesis, the selection of appropriate reagents and intermediates is crucial for achieving efficient and successful outcomes. 7-Bromo-1H-quinazolin-4-one, bearing the CAS number 194851-16-6, stands out as a strategically important compound, offering significant advantages to chemists across various disciplines. NINGBO INNO PHARMCHEM CO.,LTD. is a key player in supplying this versatile chemical building block, supporting innovation in chemical research and industry.

The primary advantage of 7-Bromo-1H-quinazolin-4-one lies in its well-defined chemical structure and reactivity. The quinazolinone core, a common motif in many biologically active molecules, is coupled with a bromine atom at the 7-position. This bromine atom serves as an ideal point for functionalization, enabling a wide array of chemical transformations, most notably palladium-catalyzed cross-coupling reactions. These reactions are fundamental for creating new carbon-carbon bonds and assembling complex molecular structures. The ability to perform selective modifications at this position makes 7-bromo-1h-quinazolin-4-one CAS 194851-16-6 a highly sought-after intermediate for sophisticated synthetic strategies.

The quality of chemical building blocks directly impacts the success of any synthetic endeavor. NINGBO INNO PHARMCHEM CO.,LTD. recognizes this and ensures that its 7-Bromo-1H-quinazolin-4-one is supplied with a high purity of at least 97%. This commitment to quality is essential for achieving reproducible results, optimizing reaction yields, and minimizing the formation of impurities. For researchers and manufacturers working on cutting-edge projects, the availability of such reliable organic chemistry intermediates is a significant strategic asset.

Beyond its role in academic research, 7-Bromo-1H-quinazolin-4-one is a valuable intermediate in the pharmaceutical industry. It is used in the synthesis of numerous drug candidates and APIs, leveraging the inherent bioactivity often associated with the quinazolinone scaffold. The ease with which this molecule can be modified allows medicinal chemists to explore diverse chemical spaces in the pursuit of novel therapeutic agents. The strategic incorporation of brominated heterocycles into drug molecules has proven to be a fruitful approach in medicinal chemistry.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing comprehensive support to its clients. By offering high-purity pharmaceutical intermediates and other essential chemicals, the company empowers researchers and manufacturers to achieve their synthetic goals efficiently. Their expertise in chemical sourcing and synthesis, coupled with a customer-focused approach, makes them a reliable partner for organizations seeking to gain a strategic advantage in their chemical endeavors. Access to key reagents like 7-Bromo-1H-quinazolin-4-one is vital for staying competitive.

In conclusion, 7-Bromo-1H-quinazolin-4-one is a strategically important compound that offers exceptional versatility and reliability in chemical synthesis. Its unique structure and reactivity, combined with the assurance of high purity from NINGBO INNO PHARMCHEM CO.,LTD., make it an indispensable tool for driving innovation in the chemical and pharmaceutical industries.